Site Activity
This page provides a monthly listing of publication activity on the Medical Policy Portal including Policy Notifications, New Policies, Updated Policies, Coding Updates, Reissued Policies, and Archived Policies. To view publication activity from prior months, select Past Site Activity.

Past Site Activity
 
                                                                                                        

Notifications
The following Independence Blue Cross Medicare Advantage policies have been posted prior to their effective date.
MA06.025i, Presumptive and Definitive Drug Testing in Substance Abuse and Pain Management Treatments
Notification: 05/17/2019 | Effective: 06/17/2019 | Posted: 05/17/2019
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

MA06.007c, Loss-of-Heterozygosity-Based Topographic Genotyping with PathFinderTG®
Notification: 05/17/2019 | Effective: 06/17/2019 | Posted: 05/17/2019
Type of policy change: Coverage and/or Reimbursement Position; Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

MA06.019b, Measurement of Serum Antibodies to and Measurement of Serum Levels of Biologics
Notification: 05/31/2019 | Effective: 07/01/2019 | Posted: 05/31/2019
Type of policy change: Coverage and/or Reimbursement Position; Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update


New Policies
The following Medicare Advantage policies have been newly developed to communicate coverage and/or reimbursement positions, reporting requirements, and other processes and procedures for doing business with Independence Blue Cross.
MA06.032, Cobalamin (Vitamin B12), Folic Acid, and Homocysteine Testing
Notification: 04/29/2019 | Effective: 05/28/2019 | Posted: 05/28/2019
Type of policy change: This is a new policy.


Updated Policies
The following Medicare Advantage policies have been reviewed and updated to communicate current coverage and/or reimbursement positions, reporting requirements, and other procedures for doing business with Independence Blue Cross.
MA11.113a, Percutaneous Coronary Intervention, Coronary Angiography and Arterial Ultrasound
Notification: 04/01/2019 | Effective: 05/01/2019 | Posted: 05/01/2019
Type of policy change: Medical Coding

MA08.016d, Treatment of Pulmonary Artery Hypertension with Intravenous, Subcutaneous, and Inhaled Pharmacologic Agents
Notification: 04/08/2019 | Effective: 05/06/2019 | Posted: 05/06/2019
Type of policy change: Coverage and/or Reimbursement Position; Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

MA11.065d, Endometrial Ablation
Effective: 05/20/2019 | Posted: 05/20/2019
Type of policy change: General Description, Guidelines, or Informational Update

MA07.023e, Upper Gastrointestinal Endoscopy (Diagnostic and Therapeutic)
Effective: 05/20/2019 | Posted: 05/20/2019
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

MA11.045c, Uterine Artery Embolization
Effective: 05/20/2019 | Posted: 05/20/2019
Type of policy change: General Description, Guidelines, or Informational Update

MA11.068d, Sentinel Lymph Node Biopsy and Mapping
Effective: 05/31/2019 | Posted: 05/31/2019
Type of policy change: Coverage and/or Reimbursement Position; Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

MA00.045c, Incident To and Non-Incident To Services Performed by Certified Registered Nurse Practitioners (CRNPs) and Physician Assistants (PAs)
Notification: 03/01/2019 | Effective: 06/01/2019 | Posted: 05/31/2019
Type of policy change: General Description, Guidelines, or Informational Update


Reissue Policies
The following Medicare Advantage policies have been reviewed, and no substantive changes were made.
MA07.005a, Ambulatory Blood Pressure Monitoring (ABPM) and Home Blood Pressure Monitoring (HBPM) Devices
Reissue Effective: 05/08/2019 | Reissue Posted: 05/09/2019

MA06.011a, Human Immunodeficiency Virus (HIV) Genotyping and Phenotyping
Reissue Effective: 05/09/2019 | Reissue Posted: 05/09/2019

MA06.029, Therapeutic Drug Monitoring for Antidepressants, Antipsychotics, and Antiepileptics
Reissue Effective: 05/09/2019 | Reissue Posted: 05/09/2019

MA09.012a, Full-Body Computerized Tomography (CT) Scan Screening
Reissue Effective: 05/09/2019 | Reissue Posted: 05/09/2019

MA06.024a, Noninvasive Techniques for the Evaluation and Monitoring of Individuals with Chronic Liver Disease
Reissue Effective: 05/09/2019 | Reissue Posted: 05/09/2019

MA06.023c, Nerve Fiber Density Testing
Reissue Effective: 05/09/2019 | Reissue Posted: 05/09/2019

MA09.014a, Computer Aided Detection (CAD) System for Use with Chest Radiographs
Reissue Effective: 05/09/2019 | Reissue Posted: 05/09/2019

MA07.015a, Evaluation and Management (E&M) of Diabetic Peripheral Neuropathy with Loss of Protective Sensation (LOPS)
Reissue Effective: 05/09/2019 | Reissue Posted: 05/09/2019

MA09.011a, Electron Beam Computed Tomography (EBCT) for Screening Evaluations
Reissue Effective: 05/09/2019 | Reissue Posted: 05/09/2019

MA11.066b, Ovarian and Internal Iliac Vein Embolization as Treatment for Pelvic Congestion Syndrome
Reissue Effective: 05/09/2019 | Reissue Posted: 05/09/2019

MA09.013a, Screening for Vertebral Fracture with Dual-Energy X-ray Absorptiometry (DEXA/DXA)
Reissue Effective: 05/09/2019 | Reissue Posted: 05/09/2019

MA05.008a, Negative Pressure Wound Therapy (NPWT) Systems
Reissue Effective: 05/22/2019 | Reissue Posted: 05/23/2019

MA05.001c, High-Frequency Chest Wall Oscillation Devices
Reissue Effective: 05/22/2019 | Reissue Posted: 05/23/2019

MA12.009, Cosmetic Procedures
Reissue Effective: 05/22/2019 | Reissue Posted: 05/23/2019

MA08.025c, Omalizumab (Xolair®)
Reissue Effective: 05/22/2019 | Reissue Posted: 05/23/2019

MA11.054b, Cataract Surgery
Reissue Effective: 05/22/2019 | Reissue Posted: 05/23/2019

MA08.067a, Repository Corticotropin (H.P. Acthar® Gel Injection)
Reissue Effective: 05/24/2019 | Reissue Posted: 05/24/2019

MA08.058c, Blinatumomab (Blincyto®)
Reissue Effective: 05/24/2019 | Reissue Posted: 05/24/2019

MA08.088b, Ocrelizumab (Ocrevus™)
Reissue Effective: 05/24/2019 | Reissue Posted: 05/24/2019


Archived Policies
Independence Blue Cross has determined that it is no longer necessary for the following Medicare Advantage policy to remain active.
MA06.009a, Computer Analysis and Generation of Automated Data in Conjunction with Diagnostic Studies
Notification: 05/03/2019 | Archive Effective: 06/03/2019 | Posted: 05/03/2019










Connect with Us        


© 2017 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.